<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33809384</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2909</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22062909</ELocationID><Abstract><AbstractText>Evidence indicates that dysfunctional heterogeneous ribonucleoprotein A1 (hnRNPA1; A1) contributes to the pathogenesis of neurodegeneration in multiple sclerosis. Understanding molecular mechanisms of neurodegeneration in multiple sclerosis may result in novel therapies that attenuate neurodegeneration, thereby improving the lives of MS patients with multiple sclerosis. Using an in vitro, blue light induced, optogenetic protein expression system containing the optogene Cryptochrome 2 and a fluorescent mCherry reporter, we examined the effects of multiple sclerosis-associated somatic A1 mutations (P275S and F281L) in A1 localization, cluster kinetics and stress granule formation in real-time. We show that A1 mutations caused cytoplasmic mislocalization, and significantly altered the kinetics of A1 cluster formation/dissociation, and the quantity and size of clusters. A1 mutations also caused stress granule formation to occur more quickly and frequently in response to blue light stimulation. This study establishes a live cell optogenetics imaging system to probe localization and association characteristics of A1. It also demonstrates that somatic mutations in A1 alter its function and promote stress granule formation, which supports the hypothesis that A1 dysfunction may exacerbate neurodegeneration in multiple sclerosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Joseph-Patrick W E</ForeName><Initials>JWE</Initials><Identifier Source="ORCID">0000-0001-5473-7479</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK S7K 0M7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thibault</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK S7K 0M7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salapa</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><Identifier Source="ORCID">0000-0001-7594-4514</Identifier><AffiliationInfo><Affiliation>Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK S7K 0M7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutchinson</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK S7K 0M7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0002-3880-9193</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK S7K 0M7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy, Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>4244</GrantID><Agency>Saskatchewan Health Research Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076245">Heterogeneous Nuclear Ribonucleoprotein A1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619656">hnRNPA1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076245" MajorTopicYN="N">Heterogeneous Nuclear Ribonucleoprotein A1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hnRNPA1</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">mutations</Keyword><Keyword MajorTopicYN="N">optogenetics</Keyword><Keyword MajorTopicYN="N">stress granules</Keyword></KeywordList><CoiStatement>The authors of this study have no current or past relationships with commercial entities, and the information contained within is not currently nor previously funded by commercial entities.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33809384</ArticleId><ArticleId IdType="pmc">PMC7998649</ArticleId><ArticleId IdType="doi">10.3390/ijms22062909</ArticleId><ArticleId IdType="pii">ijms22062909</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lassmann H., van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett. 2011;585:3715&#x2013;3723. doi: 10.1016/j.febslet.2011.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.08.004</ArticleId><ArticleId IdType="pubmed">21854776</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta R., McDonough J., Yin X., Peterson J., Chang A., Torres T., Gudz T., Macklin W.B., Lewis D.A., Fox R.J. Mitochondrial dysfunction as a cause of axonal degenerationin multiple sclerosis patients. Ann. Neurol. 2006;59:478&#x2013;489. doi: 10.1002/ana.20736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20736</ArticleId><ArticleId IdType="pubmed">16392116</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Grierson A.J., Ackerley S., Miller C.C.J. Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 2008;31:151&#x2013;173. doi: 10.1146/annurev.neuro.31.061307.090711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.31.061307.090711</ArticleId><ArticleId IdType="pubmed">18558852</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell G.R., Ziabreva I., Reeve A.K., Krishnan K.J., Reynolds R., Howell O., Lassmann H., Turnbull D.M., Mahad D.J. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann. Neurol. 2010;69:481&#x2013;492. doi: 10.1002/ana.22109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22109</ArticleId><ArticleId IdType="pmc">PMC3580047</ArticleId><ArticleId IdType="pubmed">21446022</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider L., Fischer M.T., Frischer J.M., Bauer J., H&#xf6;ftberger R., Botond G., Esterbauer H., Binder C.J., Witztum J.L., Lassmann H. Oxidative damage in multiple sclerosis lesions. Brain. 2011;134:1914&#x2013;1924. doi: 10.1093/brain/awr128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr128</ArticleId><ArticleId IdType="pmc">PMC3122372</ArticleId><ArticleId IdType="pubmed">21653539</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer M.T., Sharma R., Lim J.L., Haider L., Frischer J.M., Drexhage J., Mahad D., Bradl M., Van Horssen J., Lassmann H. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain. 2012;135:886&#x2013;899. doi: 10.1093/brain/aws012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws012</ArticleId><ArticleId IdType="pmc">PMC3286337</ArticleId><ArticleId IdType="pubmed">22366799</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W.-W., Zhang X., Huang W.-J. Role of neuroinflammation in neurodegenerative diseases (Review) Mol. Med. Rep. 2016;13:3391&#x2013;3396. doi: 10.3892/mmr.2016.4948.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.4948</ArticleId><ArticleId IdType="pmc">PMC4805095</ArticleId><ArticleId IdType="pubmed">26935478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777&#x2013;783. doi: 10.1126/science.aag2590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aag2590</ArticleId><ArticleId IdType="pubmed">27540165</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas J.N., Gardner L.A., Levin M.C. Antibodies to an Intracellular Antigen Penetrate Neuronal Cells and Cause Deleterious Effects. J. Clin. Cell. Immunol. 2013;4:1&#x2013;7. doi: 10.4172/2155-9899.1000134.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2155-9899.1000134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozin M.S., Kulakova O.G., Favorova O.O. Involvement of Mitochondria in Neurodegeneration in Multiple Sclerosis. Biochemstry. 2018;83:813&#x2013;830. doi: 10.1134/S0006297918070052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297918070052</ArticleId><ArticleId IdType="pubmed">30200866</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapp B.D., Stys P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009;8:280&#x2013;291. doi: 10.1016/S1474-4422(09)70043-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70043-2</ArticleId><ArticleId IdType="pubmed">19233038</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapp B.D., Ransohoff R., Rudick R. Axonal pathology in multiple sclerosis: Relationship to neurologic disability. Curr. Opin. Neurol. 1999;12:295&#x2013;302. doi: 10.1097/00019052-199906000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00019052-199906000-00008</ArticleId><ArticleId IdType="pubmed">10499174</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin M.C., Lee S.M., Kalume F., Morcos Y., Dohan F.C., Jr., Hasty K.A., Callaway J.C., Zunt J., Desiderio D.M., Stuart J.M. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat. Med. 2002;8:509&#x2013;513. doi: 10.1038/nm0502-509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0502-509</ArticleId><ArticleId IdType="pmc">PMC2703733</ArticleId><ArticleId IdType="pubmed">11984596</ArticleId></ArticleIdList></Reference><Reference><Citation>De March A.K., De Bouwerie M., Kolopp-Sarda M.N., Faure G.C., Bene M.C., Bernard C.C.A. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J. Neuroimmunol. 2003;135:117&#x2013;125. doi: 10.1016/S0165-5728(02)00434-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(02)00434-4</ArticleId><ArticleId IdType="pubmed">12576231</ArticleId></ArticleIdList></Reference><Reference><Citation>Craner M.J., Newcombe J., Black J.A., Hartle C., Cuzner M.L., Waxman S.G. Molecular changes in neurons in multiple sclerosis: Altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc. Natl. Acad. Sci. USA. 2004;101:8168&#x2013;8173. doi: 10.1073/pnas.0402765101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402765101</ArticleId><ArticleId IdType="pmc">PMC419575</ArticleId><ArticleId IdType="pubmed">15148385</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M., Reindl M., Lutterotti A., Kuenz B., Ehling R., Gneiss C., Lackner P., Deisenhammer F., Berger T. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments. J. Neuroimmunol. 2006;174:147&#x2013;156. doi: 10.1016/j.jneuroim.2006.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2006.01.012</ArticleId><ArticleId IdType="pubmed">16516980</ArticleId></ArticleIdList></Reference><Reference><Citation>Black J.A., Newcombe J., Trapp B.D., Waxman S.G. Sodium Channel Expression Within Chronic Multiple Sclerosis Plaques. J. Neuropathol. Exp. Neurol. 2007;66:828&#x2013;837. doi: 10.1097/nen.0b013e3181462841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e3181462841</ArticleId><ArticleId IdType="pubmed">17805013</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta R., Trapp B.D. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurological. 2007;68:S22&#x2013;S31. doi: 10.1212/01.wnl.0000275229.13012.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000275229.13012.32</ArticleId><ArticleId IdType="pubmed">17548565</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-Or A., Fawaz L., Fan B., Darlington P.J., Rieger A., Msc C.G., Calabresi P.A., Waubant E., Hauser S.L., Zhang J., et al. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann. Neurol. 2009;67:452&#x2013;461. doi: 10.1002/ana.21939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21939</ArticleId><ArticleId IdType="pubmed">20437580</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta R., Trapp B.D. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 2011;93:1&#x2013;12. doi: 10.1016/j.pneurobio.2010.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2010.09.005</ArticleId><ArticleId IdType="pmc">PMC3030928</ArticleId><ArticleId IdType="pubmed">20946934</ArticleId></ArticleIdList></Reference><Reference><Citation>Dendrou C.A., Fugger L., Friese M.A. Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 2015;15:545&#x2013;558. doi: 10.1038/nri3871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3871</ArticleId><ArticleId IdType="pubmed">26250739</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Patterson K.R., Bar-Or A. Reassessing B cell contributions in multiple sclerosis. Nat. Immunol. 2018;19:696&#x2013;707. doi: 10.1038/s41590-018-0135-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0135-x</ArticleId><ArticleId IdType="pubmed">29925992</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.M., Dunnavant F.D., Jang H., Zunt J., Levin M.C. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease. Neurosci. Lett. 2006;401:188&#x2013;193. doi: 10.1016/j.neulet.2006.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2006.03.016</ArticleId><ArticleId IdType="pmc">PMC2882438</ArticleId><ArticleId IdType="pubmed">16600502</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin M.C., Lee S., Gardner L.A., Shin Y., Douglas J.N., Cooper C. Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis. J. Clin. Cell Immunol. 2013;4 doi: 10.4172/2155-9899.1000148.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2155-9899.1000148</ArticleId><ArticleId IdType="pmc">PMC3866957</ArticleId><ArticleId IdType="pubmed">24363960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Levin M. Novel somatic single nucleotide variants within the RNA binding protein hnRNP A1 in multiple sclerosis patients. F1000Research. 2014;3:132. doi: 10.12688/f1000research.4436.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.4436.2</ArticleId><ArticleId IdType="pmc">PMC4168748</ArticleId><ArticleId IdType="pubmed">25254102</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas J.N., Gardner L.A., Salapa H.E., Levin M.C. Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis. J. Clin. Cell. Immunol. 2016;7:1&#x2013;7. doi: 10.4172/2155-9899.1000402.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2155-9899.1000402</ArticleId><ArticleId IdType="pmc">PMC4928374</ArticleId><ArticleId IdType="pubmed">27375925</ArticleId></ArticleIdList></Reference><Reference><Citation>Salapa H.E., Johnson C., Hutchinson C., Popescu B.F., Levin M.C. Dysfunctional RNA binding proteins and stress granules in multiple sclerosis. J. Neuroimmunol. 2018;324:149&#x2013;156. doi: 10.1016/j.jneuroim.2018.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2018.08.015</ArticleId><ArticleId IdType="pubmed">30190085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Salapa H.E., Levin M.C. Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis. PLoS ONE. 2019;14:e0212357. doi: 10.1371/journal.pone.0212357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212357</ArticleId><ArticleId IdType="pmc">PMC6377130</ArticleId><ArticleId IdType="pubmed">30768649</ArticleId></ArticleIdList></Reference><Reference><Citation>Libner C.D., Salapa H.E., Hutchinson C., Lee S., Levin M.C. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis. J. Comp. Neurol. 2019;528:1704&#x2013;1724. doi: 10.1002/cne.24845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24845</ArticleId><ArticleId IdType="pubmed">31872424</ArticleId></ArticleIdList></Reference><Reference><Citation>Salapa H.E., Libner C.D., Levin M.C. Dysfunctional RNA-binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female mice. J. Neurosci. Res. 2019;98:704&#x2013;717. doi: 10.1002/jnr.24554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24554</ArticleId><ArticleId IdType="pubmed">31755578</ArticleId></ArticleIdList></Reference><Reference><Citation>Salapa H.E., Hutchinson C., Popescu B.F., Levin M.C. Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex. Ann. Clin. Transl. Neurol. 2020;7:1214&#x2013;1224. doi: 10.1002/acn3.51103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51103</ArticleId><ArticleId IdType="pmc">PMC7359129</ArticleId><ArticleId IdType="pubmed">32608162</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R. RNA-protein interactions that regulate pre-mRNA splicing. Gene Expr. 2002;10:79&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977533</ArticleId><ArticleId IdType="pubmed">11868989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishore S., Luber S., Zavolan M. Deciphering the role of RNA-binding proteins in the post-transcriptional control of gene expression. Brief. Funct. Genom. 2010;9:391&#x2013;404. doi: 10.1093/bfgp/elq028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/elq028</ArticleId><ArticleId IdType="pmc">PMC3080770</ArticleId><ArticleId IdType="pubmed">21127008</ArticleId></ArticleIdList></Reference><Reference><Citation>Licatalosi D.D., Darnell R.B. RNA processing and its regulation: Global insights into biological networks. Nat. Rev. Genet. 2010;11:75&#x2013;87. doi: 10.1038/nrg2673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2673</ArticleId><ArticleId IdType="pmc">PMC3229837</ArticleId><ArticleId IdType="pubmed">20019688</ArticleId></ArticleIdList></Reference><Reference><Citation>Han K., Yeo G., An P., Burge C.B., Grabowski P.J. A Combinatorial Code for Splicing Silencing: UAGG and GGGG Motifs. PLoS Biol. 2005;3:e158. doi: 10.1371/journal.pbio.0030158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0030158</ArticleId><ArticleId IdType="pmc">PMC1079783</ArticleId><ArticleId IdType="pubmed">15828859</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy R., Durie D., Lin G., Liu B.-Q., Skehel J.M., Mauri F., Cuorvo L.V., Barbareschi M., Guo L., Holcik M., et al. hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling. Nucleic Acids Res. 2014;42:12483&#x2013;12497. doi: 10.1093/nar/gku953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku953</ArticleId><ArticleId IdType="pmc">PMC4227786</ArticleId><ArticleId IdType="pubmed">25324306</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebane A., Aab A., Steitz J.A. Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. RNA. 2004;10:590&#x2013;599. doi: 10.1261/rna.5224304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.5224304</ArticleId><ArticleId IdType="pmc">PMC1370549</ArticleId><ArticleId IdType="pubmed">15037768</ArticleId></ArticleIdList></Reference><Reference><Citation>Allemand E., Guil S., Myers M., Moscat J., C&#xe1;ceres J.F., Krainer A.R. Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc. Natl. Acad. Sci. USA. 2005;102:3605&#x2013;3610. doi: 10.1073/pnas.0409889102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409889102</ArticleId><ArticleId IdType="pmc">PMC553333</ArticleId><ArticleId IdType="pubmed">15738418</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Smith R. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell. Mol. Life Sci. 2008;66:1239&#x2013;1256. doi: 10.1007/s00018-008-8532-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-008-8532-1</ArticleId><ArticleId IdType="pmc">PMC7079774</ArticleId><ArticleId IdType="pubmed">19099192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartegni L., Maconi M., Morandi E., Cobianchi F., Riva S., Biamonti G. hnRNP A1 Selectively Interacts Through its Gly-rich Domain with Different RNA-binding Proteins. J. Mol. Biol. 1996;259:337&#x2013;348. doi: 10.1006/jmbi.1996.0324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1996.0324</ArticleId><ArticleId IdType="pubmed">8676373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisette J.-F., Toutant J., Dugr&#xe9;-Brisson S., DesGroseillers L., Chabot B. hnRNP A1 and hnRNP H can collaborate to modulate 5&#x2019; splice site selection. RNA. 2009;16:228&#x2013;238. doi: 10.1261/rna.1890310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.1890310</ArticleId><ArticleId IdType="pmc">PMC2802032</ArticleId><ArticleId IdType="pubmed">19926721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.-D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., Mittag T., Taylor J.P. Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmann T.M., Alberti S. Prion-like low-complexity sequences: Key regulators of protein solubility and phase behavior. J. Biol. Chem. 2019;294:7128&#x2013;7136. doi: 10.1074/jbc.TM118.001190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001190</ArticleId><ArticleId IdType="pmc">PMC6509491</ArticleId><ArticleId IdType="pubmed">29921587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.J., Cansizoglu A.E., Suel K.E., Louis T.H., Zhang Z., Chook Y.M. Rules for nuclear localization sequence recognition by karyopherin beta 2. Cell. 2006;126:543&#x2013;558. doi: 10.1016/j.cell.2006.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.049</ArticleId><ArticleId IdType="pmc">PMC3442361</ArticleId><ArticleId IdType="pubmed">16901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Xu L., Shin Y., Gardner L., Hartzes A., Dohan F.C., Raine C., Homayouni R., Levin M.C. A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease. J. Neuroimmunol. 2011;235:56&#x2013;69. doi: 10.1016/j.jneuroim.2011.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2011.02.007</ArticleId><ArticleId IdType="pubmed">21570130</ArticleId></ArticleIdList></Reference><Reference><Citation>De Conti L., Baralle M., Buratti E. Neurodegeneration and RNA-binding proteins. Wiley Interdiscip. Rev. RNA. 2017;8:e1394. doi: 10.1002/wrna.1394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1394</ArticleId><ArticleId IdType="pubmed">27659427</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison A.F., Shorter J. RNA-binding proteins with prion-like domains in health and disease. Biochem. J. 2017;474:1417&#x2013;1438. doi: 10.1042/BCJ20160499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160499</ArticleId><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Kim H.J., Wang H., Monaghan J., Freyermuth F., Sung J.C., O&#x2019;Donovan K., Fare C.M., Diaz Z., Singh N., et al. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. Cell. 2018;173:677&#x2013;692. doi: 10.1016/j.cell.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann J.R., Gleixner A.M., Mauna J.C., Gomes E., DeChellis-Marks M.R., Needham P.G., Copley K.E., Hurtle B., Portz B., Pyles N.J., et al. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019;102:321&#x2013;338.e8. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.G., Lee H., Lee S.B. Mechanisms of protein toxicity in neurodegenerative diseases. Cell. Mol. Life Sci. 2018;75:3159&#x2013;3180. doi: 10.1007/s00018-018-2854-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2854-4</ArticleId><ArticleId IdType="pmc">PMC6063327</ArticleId><ArticleId IdType="pubmed">29947927</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter D.S., Rao B.S., Van Treeck B., Lin Y., Mizoue L., Rosen M.K., Parker R. Intrinsically Disordered Regions Can Contribute Promiscuous Interactions to RNP Granule Assembly. Cell Rep. 2018;22:1401&#x2013;1412. doi: 10.1016/j.celrep.2018.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.01.036</ArticleId><ArticleId IdType="pmc">PMC5824733</ArticleId><ArticleId IdType="pubmed">29425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittag T., Parker R. Multiple Modes of Protein&#x2013;Protein Interactions Promote RNP Granule Assembly. J. Mol. Biol. 2018;430:4636&#x2013;4649. doi: 10.1016/j.jmb.2018.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.08.005</ArticleId><ArticleId IdType="pmc">PMC6204294</ArticleId><ArticleId IdType="pubmed">30099026</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter D.S., Parker R. Principles and Properties of Stress Granules. Trends Cell Biol. 2016;26:668&#x2013;679. doi: 10.1016/j.tcb.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.05.004</ArticleId><ArticleId IdType="pmc">PMC4993645</ArticleId><ArticleId IdType="pubmed">27289443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler J.R., Matheny T., Jain S., Abrisch R., Parker R. Distinct stages in stress granule assembly and disassembly. eLife. 2016;5:e18413. doi: 10.7554/eLife.18413.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.18413</ArticleId><ArticleId IdType="pmc">PMC5014549</ArticleId><ArticleId IdType="pubmed">27602576</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman A.A., Weber C.A., J&#xfc;licher F. Liquid-Liquid Phase Separation in Biology. Annu. Rev. Cell Dev. Biol. 2014;30:39&#x2013;58. doi: 10.1146/annurev-cellbio-100913-013325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100913-013325</ArticleId><ArticleId IdType="pubmed">25288112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zuo Z., Wang X., Gu L., Yoshizumi T., Yang Z., Yang L., Liu Q., Liu W., Han Y.-J., et al. Photoactivation and inactivation of Arabidopsis cryptochrome 2. Science. 2016;354:343&#x2013;347. doi: 10.1126/science.aaf9030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf9030</ArticleId><ArticleId IdType="pmc">PMC6180212</ArticleId><ArticleId IdType="pubmed">27846570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Fan B., Yang P., Temirov J., Messing J., Kim H.J., Taylor J.P. Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. eLife. 2019;8 doi: 10.7554/eLife.39578.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.39578</ArticleId><ArticleId IdType="pmc">PMC6426440</ArticleId><ArticleId IdType="pubmed">30893049</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y., Berry J., Pannucci N., Haataja M.P., Toettcher J.E., Brangwynne C.P. Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets. Cell. 2017;168:159&#x2013;171. doi: 10.1016/j.cell.2016.11.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.054</ArticleId><ArticleId IdType="pmc">PMC5562165</ArticleId><ArticleId IdType="pubmed">28041848</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourriere H., Chebli K., Zekri L., Courselaud B., Blanchard J.M., Bertrand E., Tazi J. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J. Cell Biol. 2003;160:823&#x2013;831. doi: 10.1083/jcb.200212128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200212128</ArticleId><ArticleId IdType="pmc">PMC2173781</ArticleId><ArticleId IdType="pubmed">12642610</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N., Chen S., Gilks N., Li W., Miller I.J., Stahl J., Anderson P. Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol. Biol. Cell. 2002;13:195&#x2013;210. doi: 10.1091/mbc.01-05-0221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.01-05-0221</ArticleId><ArticleId IdType="pmc">PMC65082</ArticleId><ArticleId IdType="pubmed">11809833</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi M., Higuchi M., Matsuki H., Yoshita M., Ohsawa T., Oie M., Fujii M. Stress Granules Inhibit Apoptosis by Reducing Reactive Oxygen Species Production. Mol. Cell. Biol. 2013;33:815&#x2013;829. doi: 10.1128/MCB.00763-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00763-12</ArticleId><ArticleId IdType="pmc">PMC3571346</ArticleId><ArticleId IdType="pubmed">23230274</ArticleId></ArticleIdList></Reference><Reference><Citation>Reineke L.C., Dougherty J.D., Pierre P., Lloyd R.E. Large G3BP-induced granules trigger eIF2&#x3b1; phosphorylation. Mol. Biol. Cell. 2012;23:3499&#x2013;3510. doi: 10.1091/mbc.e12-05-0385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e12-05-0385</ArticleId><ArticleId IdType="pmc">PMC3442399</ArticleId><ArticleId IdType="pubmed">22833567</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracha D., Walls M.T., Wei M.-T., Zhu L., Kurian M., Avalos J.L., Toettcher J.E., Brangwynne C.P. Mapping Local and Global Liquid Phase Behavior in Living Cells Using Photo-Oligomerizable Seeds. Cell. 2018;175:1467&#x2013;1480. doi: 10.1016/j.cell.2018.10.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.10.048</ArticleId><ArticleId IdType="pmc">PMC6724719</ArticleId><ArticleId IdType="pubmed">30500534</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S., Usluer S., Bourgeois B., Simonetti F., Odeh H.M., Fare C.M., Czuppa M., Hruska-Plochan M., Hofweber M., Polymenidou M., et al. Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions. Cell Rep. 2020;33:108538. doi: 10.1016/j.celrep.2020.108538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108538</ArticleId><ArticleId IdType="pmc">PMC7814465</ArticleId><ArticleId IdType="pubmed">33357437</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J., Taylor J.P. Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly. Rare Dis. 2013;1:e25200. doi: 10.4161/rdis.25200.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rdis.25200</ArticleId><ArticleId IdType="pmc">PMC3932941</ArticleId><ArticleId IdType="pubmed">25002999</ArticleId></ArticleIdList></Reference><Reference><Citation>Guil S., Long J.C., C&#xe1;ceres J.F. hnRNP A1 Relocalization to the Stress Granules Reflects a Role in the Stress Response. Mol. Cell. Biol. 2006;26:5744&#x2013;5758. doi: 10.1128/MCB.00224-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00224-06</ArticleId><ArticleId IdType="pmc">PMC1592774</ArticleId><ArticleId IdType="pubmed">16847328</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S., Soltanieh S., Server K.L., Mak R., Jin W., Fang M.Y., Luo E.-C., Krach F., Yang D., Sen A., et al. Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules. Cell. 2018;172:590&#x2013;604. doi: 10.1016/j.cell.2017.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.032</ArticleId><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn J.-Y., Dyakov B.J., Zhang J., Knight J.D., Vernon R.M., Forman-Kay J.D., Gingras A.-C. Properties of Stress Granule and P-Body Proteomes. Mol. Cell. 2019;76:286&#x2013;294. doi: 10.1016/j.molcel.2019.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.014</ArticleId><ArticleId IdType="pubmed">31626750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui X., Luo F., Li Y., Zhou H., Qin Z., Liu Z., Gu J., Xie M., Zhao K., Dai B., et al. Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly. Nat. Commun. 2019;10:1&#x2013;12. doi: 10.1038/s41467-019-09902-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09902-7</ArticleId><ArticleId IdType="pmc">PMC6494871</ArticleId><ArticleId IdType="pubmed">31043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Iervolino A., Santilli G., Trotta R., Guerzoni C., Cesi V., Bergamaschi A., Passerini C.G., Calabretta B., Perrotti D. hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis. Mol. Cell. Biol. 2002;22:2255&#x2013;2266. doi: 10.1128/MCB.22.7.2255-2266.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.7.2255-2266.2002</ArticleId><ArticleId IdType="pmc">PMC133663</ArticleId><ArticleId IdType="pubmed">11884611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton B.J., Burns C.M., Nichols R.C., Rigby W.F.C. Modulation of AUUUA Response Element Binding by Heterogeneous Nuclear Ribonucleoprotein A1 in Human T Lymphocytes. The roles of cytoplasmic location, transcription, and phosphorylation. J. Biol. Chem. 1997;272:28732&#x2013;28741. doi: 10.1074/jbc.272.45.28732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.45.28732</ArticleId><ArticleId IdType="pubmed">9353343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajani D.K., Walch M., Martinvalet D., Thomas M.P., Lieberman J. Alterations in RNA processing during immune-mediated programmed cell death. Proc. Natl. Acad. Sci. USA. 2012;109:8688&#x2013;8693. doi: 10.1073/pnas.1201327109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1201327109</ArticleId><ArticleId IdType="pmc">PMC3365155</ArticleId><ArticleId IdType="pubmed">22589304</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegretta M., Nicklas J.A., Sriram S., Albertini R.J. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science. 1990;247:718&#x2013;721. doi: 10.1126/science.1689076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1689076</ArticleId><ArticleId IdType="pubmed">1689076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodge P.A., Allegretta M., Steinman L., Sriram S. Myelin basic protein peptide specificity and T-cell receptor gene usage of HPRT mutant T-cell clones in patients with multiple sclerosis. Ann. Neurol. 1994;36:734&#x2013;740. doi: 10.1002/ana.410360508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410360508</ArticleId><ArticleId IdType="pubmed">7526775</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori M., Jansson L., Kiviharju A., Ellonen P., Rajala H., Awad S.A., Mustjoki S., Tienari P.J. A novel class of somatic mutations in blood detected preferentially in CD8 + cells. Clin. Immunol. 2017;175:75&#x2013;81. doi: 10.1016/j.clim.2016.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.11.018</ArticleId><ArticleId IdType="pmc">PMC5341785</ArticleId><ArticleId IdType="pubmed">27932211</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Horebeek L., Hilven K., Mallants K., Van Nieuwenhuijze A., Kelkka T., Savola P., Mustjoki S., Schlenner S.M., Liston A., Dubois B., et al. A robust pipeline with high replication rate for detection of somatic variants in the adaptive immune system as a source of common genetic variation in autoimmune disease. Hum. Mol. Genet. 2019;28:1369&#x2013;1380. doi: 10.1093/hmg/ddy425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy425</ArticleId><ArticleId IdType="pmc">PMC6452186</ArticleId><ArticleId IdType="pubmed">30541027</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Shu S., Wang R.R., Liu F., Cui B., Guo X.N., Lu C.X., Li X.G., Liu M.S., Peng B., et al. Whole-exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS. Neurological. 2016;87:1763&#x2013;1769. doi: 10.1212/WNL.0000000000003256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003256</ArticleId><ArticleId IdType="pubmed">27694260</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H., Ishiura H., Mitsui J., Date H., Takahashi Y., Matsukawa T., Tanaka M., Ishii A., Tamaoka A., Hokkoku K., et al. Molecular epidemiological study of familial amyotrophic lateral sclerosis in Japanese population by whole-exome sequencing and identification of novel HNRNPA1 mutation. Neurobiol. Aging. 2018;61:255.e9&#x2013;255.e16. doi: 10.1016/j.neurobiolaging.2017.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.030</ArticleId><ArticleId IdType="pubmed">29033165</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nat. Cell Biol. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeb O., Nabulsi M. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study. Curr. Top. Med. Chem. 2020;20:2391&#x2013;2403. doi: 10.2174/1568026620666200924114827.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026620666200924114827</ArticleId><ArticleId IdType="pubmed">32972341</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahi-Buisson N., Souville I., Fourniol F.J., Toussaint A., Moores C.A., Houdusse A., Lemaitre J.Y., Poirier K., Khalaf-Nazzal R., Hully M., et al. New insights into genotype&#x2013;phenotype correlations for the doublecortin-related lissencephaly spectrum. Brain. 2013;136:223&#x2013;244. doi: 10.1093/brain/aws323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws323</ArticleId><ArticleId IdType="pmc">PMC3562079</ArticleId><ArticleId IdType="pubmed">23365099</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Ramos A., Picher A.J., Garc&#xed;a E., Garrido P., Hernandez F., Soriano E., Avila J. Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer&#x2019;s Disease Patients. J. Alzheimer&#x2019;s Dis. 2017;56:977&#x2013;990. doi: 10.3233/JAD-161053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161053</ArticleId><ArticleId IdType="pubmed">28106558</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell M.J., Moran J.V., Abyzov A., Akbarian S., Bae T., Cortes-Ciriano I., Erwin J.A., Fasching L., Flasch D.A., Freed D., et al. Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network. Science. 2017;356:eaal1641. doi: 10.1126/science.aal1641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal1641</ArticleId><ArticleId IdType="pmc">PMC5558435</ArticleId><ArticleId IdType="pubmed">28450582</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>